{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:28:03Z","timestamp":1790328483183,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.pbb.2013.01.009","type":"journal-article","created":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T21:48:37Z","timestamp":1359755317000},"page":"89-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Behavioural effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficit\/hyperactivity disorder"],"prefix":"10.1016","volume":"105","author":[{"given":"Sachiko","family":"Hiraide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machiko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Yanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Togashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2013.01.009_bb0005","series-title":"Diagnostic and statistical manual of mental disorders DSM-IV-TR","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.pbb.2013.01.009_bb0010","first-page":"1000104","article-title":"Epigenetics in developmental disorder: ADHD and endophenotypes","volume":"104","author":"Archer","year":"2011","journal-title":"J Genet Syndr Gene Ther"},{"key":"10.1016\/j.pbb.2013.01.009_bb0015","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1038\/sj.npp.1301164","article-title":"Stimulants: therapeutic actions in ADHD","volume":"31","author":"Arnsten","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2013.01.009_bb0020","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0006-3223(99)00140-7","article-title":"Role of locus coeruleus in attention and behavioral flexibility","volume":"46","author":"Aston-Jones","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.009_bb0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00213-011-2576-x","article-title":"Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats","volume":"219","author":"Baarendse","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2013.01.009_bb0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/scientificamerican0998-66","article-title":"Attention-deficit hyperactivity disorder","volume":"279","author":"Barkley","year":"1998","journal-title":"Sci Am"},{"key":"10.1016\/j.pbb.2013.01.009_bb0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0006-3223(00)01053-2","article-title":"Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit\/hyperactivity disorder","volume":"49","author":"Barr","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.009_bb0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1017\/S0033291700025332","article-title":"Noradrenergic modulation of cognitive function: clinical implications of anatomical, electrophysiological and behavioural studies in animal models","volume":"23","author":"Berridge","year":"1993","journal-title":"Psychol Med"},{"key":"10.1016\/j.pbb.2013.01.009_bb0045","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1176\/ajp.152.3.431","article-title":"High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study","volume":"152","author":"Biederman","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.009_bb0050","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-4159.1990.tb04599.x","article-title":"Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals","volume":"55","author":"Carboni","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2013.01.009_bb0055","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neuron.2011.01.020","article-title":"Impulsivity, compulsivity, and top-down cognitive control","volume":"69","author":"Dalley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2013.01.009_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(02)00274-6","article-title":"Animal models of attention-deficit hyperactivity disorder","volume":"42","author":"Davids","year":"2003","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pbb.2013.01.009_bb0065","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/S0140-6736(99)04030-1","article-title":"Dopamine transporter density in patients with attention deficit hyperactivity disorder","volume":"354","author":"Dougherty","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2013.01.009_bb0070","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1017\/S0954579408000539","article-title":"Converging methods in studying attention-deficit\/hyperactivity disorder: what can we learn from neuroimaging and genetics?","volume":"20","author":"Durston","year":"2008","journal-title":"Dev Psychopathol"},{"key":"10.1016\/j.pbb.2013.01.009_bb0075","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/PL00005487","article-title":"The pharmacology of impulsive behaviour in rats VII: the effects of serotonergic agonists and antagonists on responding under a discrimination task using unreliable visual stimuli","volume":"146","author":"Evenden","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl. 8","key":"10.1016\/j.pbb.2013.01.009_bb0080","first-page":"13","article-title":"Candidate gene studies of attention-deficit\/hyperactivity disorder","volume":"67","author":"Faraone","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.009_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.283.5400.397","article-title":"Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity","volume":"283","author":"Gainetdinov","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pbb.2013.01.009_bb0090","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/sj.mp.4001048","article-title":"Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample","volume":"7","author":"Hawi","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.009_bb0095","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/archpsyc.1992.01820060016002","article-title":"Cerebrospinal fluid monoamine and adrenal correlates of aggression in free-ranging rhesus monkeys","volume":"49","author":"Higley","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.009_bb0100","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0364-7722(81)90099-0","article-title":"Dopaminergic involvement in attention: a novel animal model","volume":"4","author":"Katz","year":"1980","journal-title":"Prog Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2013.01.009_bb0105","unstructured":"Kimura S, Hiraide S, Shikanai H, Ohashi A, Matsumoto M, Togashi H, et al. Dopaminergic modulation of synaptic plasticity in the prefrontal cortex of attention-deficit\/hyperactivity disorder model rats. Biog Amines in press."},{"key":"10.1016\/j.pbb.2013.01.009_bb0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3940(00)01040-5","article-title":"Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography","volume":"285","author":"Krause","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2013.01.009_bb0115","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1176\/ajp.151.11.1673","article-title":"DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents","volume":"151","author":"Lahey","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.009_bb0120","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.biopsych.2004.10.011","article-title":"The dopamine transporter and attention-deficit\/hyperactivity disorder","volume":"57","author":"Madras","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.009_bb0125","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1176\/ajp.151.10.1485","article-title":"Low CSF 5-HIAA concentrations and severe aggression and impaired impulse control in nonhuman primates","volume":"151","author":"Mehlman","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.009_bb0130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1523\/JNEUROSCI.22-02-00389.2002","article-title":"Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines","volume":"22","author":"Mor\u00f3n","year":"2002","journal-title":"J Neurosci"},{"issue":"Suppl. I","key":"10.1016\/j.pbb.2013.01.009_bb0135","first-page":"143","article-title":"Establishment of the stroke-prone spontaneously hypertensive rat (SHR)","volume":"34\/35","author":"Okamoto","year":"1974","journal-title":"Circ Res"},{"key":"10.1016\/j.pbb.2013.01.009_bb0145","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0091-3057(86)90552-6","article-title":"Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat","volume":"24","author":"Pellow","year":"1986","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2013.01.009_bb0140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.pbb.2013.01.009_bb0150","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00004583-198911000-00012","article-title":"Effect of anxiety on cognition, behavior, and stimulant response in ADHD","volume":"28","author":"Pliszka","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.009_bb0155","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11055-008-9004-7","article-title":"From gene to aggressive behaviour: the role of brain serotonin","volume":"38","author":"Popova","year":"2008","journal-title":"Neurosci Behav Physiol"},{"key":"10.1016\/j.pbb.2013.01.009_bb0160","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/sj.mp.4001244","article-title":"The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder","volume":"8","author":"Quist","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.009_bb0165","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00212843","article-title":"Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and agonist beta-carbolines","volume":"94","author":"Sarter","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2013.01.009_bb0170","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0006-8993(76)90141-4","article-title":"The action of norepinephrine in the rat hippocampus. IV. The effects of locus coeruleus stimulation on evoked hippocampal unit activity","volume":"107","author":"Segal","year":"1976","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2013.01.009_bb0175","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1054-3589(08)60720-6","article-title":"Cellular and subcellular localization of the dopamine transporter in rat cortex","volume":"42","author":"Sesack","year":"1998","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.pbb.2013.01.009_bb0180","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.neuropharm.2009.08.011","article-title":"Genetics of attention-deficit hyperactivity disorder (ADHD)","volume":"57","author":"Sharp","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.01.009_bb0185","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.biopsych.2005.07.017","article-title":"Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD","volume":"59","author":"Smoller","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.009_bb0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1010329714819","article-title":"The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD\/HD: a supplement to the NIMH multimodal treatment study of AD\/HD","volume":"29","author":"Solanto","year":"2001","journal-title":"J Abnorm Child Psychol"},{"key":"10.1016\/j.pbb.2013.01.009_bb0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11065-007-9019-9","article-title":"Etiologic subtypes of attention-deficit\/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis","volume":"17","author":"Swanson","year":"2007","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.pbb.2013.01.009_bb0200","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00004583-198911000-00010","article-title":"ADHD and conduct disorder: degree of diagnostic overlap and differences among correlates","volume":"28","author":"Szatmari","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.009_bb0205","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1460-9568.1997.tb01375.x","article-title":"Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine","volume":"9","author":"Tanda","year":"1997","journal-title":"Eur J Neurosci"},{"issue":"Suppl. 1","key":"10.1016\/j.pbb.2013.01.009_bb0210","first-page":"17","article-title":"European clinical guidelines for hyperkinetic disorder-first upgrade","volume":"13","author":"Taylor","year":"2004","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.pbb.2013.01.009_bb0215","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/hmg\/ddi263","article-title":"The genetics of attention deficit hyperactivity disorder","volume":"14","author":"Thapar","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pbb.2013.01.009_bb0220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3940(94)90854-0","article-title":"Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats","volume":"166","author":"Togashi","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2013.01.009_bb0225","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1163\/1569391041501951","article-title":"Anxiety-related behavior in juvenile stroke-prone spontaneously hypertensive rats \u2014 an animal model of attention-deficit\/hyperactivity disorder","volume":"18","author":"Togashi","year":"2004","journal-title":"Biog Amines"},{"key":"10.1016\/j.pbb.2013.01.009_bb0230","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/jpet.302.1.95","article-title":"Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder","volume":"302","author":"Ueno","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2013.01.009_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008877-200202000-00001","article-title":"Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder","volume":"13","author":"Ueno","year":"2002","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2013.01.009_bb0240","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1163\/15693910260698267","article-title":"Juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention deficit\/hyperactivity disorder","volume":"17","author":"Ueno","year":"2002","journal-title":"Biog Amines"},{"key":"10.1016\/j.pbb.2013.01.009_bb0245","first-page":"47","article-title":"Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit\/hyperactivity disorder","volume":"23","author":"Ueno","year":"2003","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"key":"10.1016\/j.pbb.2013.01.009_bb0250","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/PL00005489","article-title":"CSF 5-HIAA and aggression in female macaque monkeys: species and interindividual differences","volume":"146","author":"Westergaard","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2013.01.009_bb0255","first-page":"10p","article-title":"Behavioral characterization of SHR substrains as an ADHD animal model","volume":"61","author":"Yamaguchi","year":"2012","journal-title":"Physiol Res"},{"key":"10.1016\/j.pbb.2013.01.009_bb0260","series-title":"Abstract in the 46th annual meeting of SFN 2012b; 654.17\/J17","article-title":"Abundant expression of noradrenaline transporters in the prefrontal cortex of the ADHD model rat","author":"Yamaguchi","year":"2012"},{"key":"10.1016\/j.pbb.2013.01.009_bb0265","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1471-4159.1998.71010274.x","article-title":"Regulation of extracellular dopamine by the norepinephrine transporter","volume":"71","author":"Yamamoto","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2013.01.009_bb0270","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/hup.896","article-title":"Serotonergic functioning and trait-impulsivity in attention-deficit\/hyperactivity-disordered boys (ADHD): influence of rapid tryptophan depletion","volume":"23","author":"Zepf","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pbb.2013.01.009_bb0275","doi-asserted-by":"crossref","first-page":"e32023","DOI":"10.1371\/journal.pone.0032023","article-title":"The effects of acute tryptophan depletion on reactive aggression in adults with attention-deficit\/hyperactivity disorder (ADHD) and healthy controls","volume":"7","author":"Zimmermann","year":"2012","journal-title":"PLoS One"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713000130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713000130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T04:21:10Z","timestamp":1562646070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305713000130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":55,"alternative-id":["S0091305713000130"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2013.01.009","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioural effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficit\/hyperactivity disorder","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2013.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}